Healthcare AI mirrors decades of gender bias. Women-led startups are rebuilding it to reduce misdiagnosis, dismissal, and ...
The "little pink pill" is now available to even more women. The Food and Drug Administration (FDA) just approved Addyi for ...
How Wisp built telehealth for women that delivers same-day care, overcomes stigma, and remains profitable amid healthcare ...
While the expanded approval fulfills an unmet meet in postmenopausal women, its benefits are marginal in that population.
On Dec. 15, Sprout Pharmaceuticals received approval to use its pill, Addyi (flibanserin), to treat low sexual desire in ...
Addyi (flibanserin) was cleared a decade ago to treat low sex drive in women before menopause. A new FDA action allows ...
Celebrity nutritionist Rujuta Diwekar calls menopause a natural transition, urges women to prioritise sexual health and flags ...
For the first time, postmenopausal women have an FDA-approved treatment for low desire. Eckert explains why that validation ...
U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by women older than 65.
The tech company, which owns Facebook and WhatsApp amongst others, has reportedly blocked or limited access to abortion ...
Subtle sexism that pervades everyday life often gets shrugged off. But research shows it can still have lasting psychological effects – including "thinning" parts of the brain.
Women and girls from Mali are alleging rape and sexual assault by Russian fighters with Africa Corps, a new military unit ...